FARROW JEFFREY S (See Remarks) sold 12.9% of their position (6.43K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $439.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/19/2026ACC: 0001405253-26-000007
Officer· See Remarks
Since Mar 2026
-6.43K
Net shares
Net seller
$439.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
6.43K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.11K
Price / share
$69.42
Trade value
$146.55K
% of position
4.2%
3/17/2026
49.75K→47.63K
Common Stock
Direct
Shares
−2.13K
Price / share
$68.71
Trade value
$146.56K
% of position
4.5%
3/18/2026
47.63K→45.50K
Common Stock
Direct
Shares
−2.19K
Price / share
$67.00
Trade value
$146.46K
% of position
4.8%
3/19/2026
45.50K→43.32K
Total
Net shares
−6.43K
Net value
-$439.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −2.11K | $69.42 | $146.55K | 4.2% | 49.75K | 47.63K |
| Common Stock Direct | 3/18/2026 | S · Sale | −2.13K | $68.71 | $146.56K | 4.5% | 47.63K | 45.50K |
| Common Stock Direct | 3/19/2026 | S · Sale | −2.19K | $67.00 | $146.46K | 4.8% | 45.50K | 43.32K |
| Total | −6.43K | -$439.57K | ||||||
Derivative Transactions0
No derivative transactions reported